MIS Execs Allegedly Defrauded FDA During Acquisition Talks With Medtronic
This article was originally published in The Gray Sheet
Executive Summary
While Micro Interventional Systems was in discussions with Medtronic about a possible acquisition in November 1995, two executives at the Sunnyvale, California-based firm allegedly were falsifying data in various 510(k) submissions to FDA in an apparent attempt to impress Medtronic with the breadth of MIS' neurovascular product pipeline.
You may also be interested in...
Predicate Device Removal May Trigger 510(k) Rescissions - Proposed Rule
FDA's Center for Devices and Radiological Health may rescind 510(k) clearance for a device if its predicate is removed from the market "for safety or effectiveness reasons" by either FDA or the product's manufacturer, the agency states in a Jan. 16 proposed rule.
Predicate Device Removal May Trigger 510(k) Rescissions - Proposed Rule
FDA's Center for Devices and Radiological Health may rescind 510(k) clearance for a device if its predicate is removed from the market "for safety or effectiveness reasons" by either FDA or the product's manufacturer, the agency states in a Jan. 16 proposed rule.
Medtronic Voluntary Response To MIS Data Integrity Problems Averts AIP
Medtronic's voluntary actions to ensure data integrity in premarket submissions from its Micro Interventional Systems unit appears to have helped avert imposition of FDA's application integrity policy.